Mologen AG

ots Ad hoc-Service: Mologen Holding AG Mologen: New acquisition and new co-operation

Ad hoc-announcement. The sender is solely responsible for the contents of this announcement. -----------------------------------------------------

    Berlin (ots Ad hoc-Service) - Mologen Holding AG has acquired 51% of bcd biomedical consulting + development GmbH in Berlin. bcd is specialised in providing services and R&D-capacity for genetic vaccination and somatic gene therapy in animals. bcd and Mologen expect from this deal a powerful combination of the specific know how of both companies.

    Mologen regard this investment as another important strategic element for strengthening their application-oriented R&D. The establishment of the wholly owned Mologen Molecular Medicine S.L. in Spain in 2000 has been the first step in realising this strategy.

    A further element is a co-operation with Weston Medical Group plc. Both companies have started to develop new application methods for genetic vaccination of humans by combining the core technologies of both companies. Mologen contributes the MIDGE technology, Weston Medical provides with Intraject one of the leading technologies in needlefree injection.

    For further information please go to

    WKN: 663720; Index: Listed: Freiverkehr in Berlin, Frankfurt, Hamburg, München und Stuttgart

    End ----------------------------------------------------- Internet:

Original-Content von: Mologen AG, übermittelt durch news aktuell

Weitere Meldungen: Mologen AG

Das könnte Sie auch interessieren: